🇧🇷 Kyprolis in Brazil

Kyprolis (carfilzomib) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Kyprolis in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Kyprolis approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Kyprolis in Brazil?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.